A consensus conference with representatives from academia, governmental agencies, and the pharmaceutical industry met and concluded that clinical trials designed to assess the efficacy and effectiveness of treatments for chronic pain should consider outcomes in six core domains: pain, physical functioning, emotional functioning, patient global ratings of satisfaction, negative health states and adverse events, and patient disposition. In addition, it was acknowledged that there are many secondary domains that might be of importance and should be included in trials depending on the nature of the treatment and population to whom the treatment is targeted.
AimThe IMMPACT group meeting focused on the identification of a core set of domains that should be considered in all clinical trials of treatments for chronic pain.
ContributorsTurk, Dennis C. Dworkin, Robert H.
Disease Category: Anaesthesia & pain control
Disease Name: Pain (chronic)
Age Range: 18 - 100
Sex: Either
Nature of Intervention: Not specified
- Pharmaceutical industry representatives
- Academic research representatives
- Governmental agencies
- Commentary
- Consensus meeting
This paper is based on the consensus meeting of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials
(IMMPACT) held in Annapolis, Maryland, on 1 and 2 November 2002. An extended version of the material summarized in this paper appeared in Pain 2003, 106:337-345.